2024/11/01 09:06:16 | |
---|---|
Price | |
44.49 EUR | |
Difference | -0.36% (-0.16) |
ISIN | FI0009014377 |
Symbol | ORNBV |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,272 EUR |
Benchmark | OMX HELSINKI 25 |
Bid (Bid size) | 45.29 EUR (1,000) |
Ask (Ask size) | 45.37 EUR (1,000) |
Open | 44.49 EUR |
High | 44.49 EUR |
Low | 44.49 EUR |
Close (prev. day) | 44.65 EUR |
VWAP | 46.58 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | 27 |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2024/11/01 09:06:16 | |
---|---|
Price | |
44.49 EUR | |
Difference | -0.36% (-0.16) |
ISIN | FI0009014377 |
Symbol | ORNBV |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,272 EUR |
Benchmark | OMX HELSINKI 25 |
Bid (Bid size) | 45.29 EUR (1,000) |
Ask (Ask size) | 45.37 EUR (1,000) |
Open | 44.49 EUR |
High | 44.49 EUR |
Low | 44.49 EUR |
Close (prev. day) | 44.65 EUR |
VWAP | 46.58 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6M | 1Y | 3Y | |
Perf (%) | +25.21% | +18.84% | +18.88% |
Perf (abs.) | +8.99 | +7.08 | +7.09 |
Beta | 0.54 | 0.56 | 0.40 |
Volatility | 21.82 | 24.21 | 28.59 |
Ø price 5 days | Ø volume 5 days (pcs.) | 44.55 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 47.37 EUR (55) |
Ø price 100 days | Ø volume 100 days (pcs.) | 44.53 EUR (28) |
Ø price 250 days | Ø volume 250 days (pcs.) | 40.41 EUR (20) |
YTD High | date | 49.88 EUR (2024/09/26) |
YTD Low | date | 32.01 EUR (2024/04/19) |
52 Weeks High | date | 49.88 EUR (2024/09/26) |
52 Weeks Low | date | 32.01 EUR (2024/04/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/11/01 | 10:48 | 44.79 EUR | 0.00 | 2 |
Stuttgart | 2024/11/01 | 09:26 | 44.50 EUR | 0.00 | 2 |
Nasdaq Helsinki | 2024/11/01 | 12:19 | 45.34 EUR | 1.16 | 573 |
Munich | 2024/11/01 | 08:04 | 44.71 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/11/01 | 09:00 | 44.64 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 09:06 | 44.49 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/01/25 | 17:14 | 47.16 USD | 0.06 | 2 |
Euronext Milan MTF Trading After Hours | 2024/07/03 | 18:00 | 42.82 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/31 | 17:44 | 45.10 EUR | 0.00 | 1 |
Duesseldorf | 2024/11/01 | 08:10 | 44.57 EUR | 0.00 | 1 |
Berlin | 2024/11/01 | 08:04 | 44.71 EUR | 0.00 | 1 |
ORION OYJ |
- - |
Orionintie 1A - 02200 Espoo |
Telefon: +358-10-4261 |
Fax: + |
E-mail: - |
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland. |
Liisa Hurme | Chairman of Managing Board |
Hao Pan | Member of Executive Committee |
Jani Korhonen | Member of Executive Committee |
Jari Karlson | Member of Executive Committee |
Juhani Kankaanpää | Member of Executive Committee |
Julia Macharey | Member of Executive Committee |
Niclas Lindstedt | Member of Executive Committee |
Olli Huotari | Member of Executive Committee |
Outi Vaarala | Member of Executive Committee |
Satu Ahomäki | Member of Executive Committee |
Virve Laitinen | Member of Executive Committee |
Veli-Matti Johannes Mattila | Chairman of Supervisory Board |
Ari Tapio Lehtoranta | Member of Supervisory Board |
Hilpi Rautelin | Member of Supervisory Board |
Eija Ronkainen | Member of Supervisory Board |
Henrik Stenqvist | Member of Supervisory Board |
Karen Sörensen | Member of Supervisory Board |
Kari Jussi Aho | Member of Supervisory Board |
Maziar Mike Doustdar | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.